B41.7
Disseminated paracoccidioidomycosis
Clinical Classification Guidelines
Inclusion Terms
- Generalized paracoccidioidomycosis
Medical Intelligence & Overview
Disseminated paracoccidioidomycosis is a serious fungal infection caused by the Paracoccidioides species. This condition primarily affects individuals in regions where the fungus is endemic, such as parts of Central and South America. When the infection spreads throughout the body, it is known as disseminated paracoccidioidomycosis, leading to widespread symptoms and requiring comprehensive medical management.
Causes & Symptoms
Clinical Causes: Inhalation of airborne spores from the Paracoccidioides fungus, often found in soil Prolonged exposure to environments contaminated with the fungal spores Weakening of the immune system, which may increase susceptibility Age and geographical location, with higher prevalence in rural areas
Key Symptoms: Chronic cough and chest pain Difficulty breathing or shortness of breath Multiple skin lesions, ulcers, or nodules Swelling and pain in lymph nodes Muscle and joint pains Fever and night sweats Weight loss and fatigue Mucosal ulcers in the mouth and nose Involvement of internal organs like liver, spleen, and bones, leading to diverse symptoms
Diagnostic & Treatment
Diagnosis Path: Microscopic examination of tissue or lesion samples for the characteristic yeast forms Fungal cultures to grow and identify Paracoccidioides species Serological tests to detect specific antibodies or antigens Imaging studies such as chest X-rays or CT scans to assess internal organ involvement Biopsy of affected tissues for histopathological analysis
Treatment Protocols: Initial administration of amphotericin B in severe cases, especially with internal organ involvement Long-term oral antifungal medications like itraconazole or sulfadiazine Supportive care to manage symptoms and prevent secondary infections Monitoring of treatment response through clinical assessment and laboratory tests Adjunct therapies such as nutritional support and immune system management
Clinical Advice & FAQs
Billing Guidance
Is B41.7 a billable ICD-10 code?
Yes, B41.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B41.7?
Clinical documentation must specify the nature of Disseminated paracoccidioidomycosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
